(Q35759053)

10 August 2017

title

Biomarker analysis of Morquio syndrome: identification of disease state and drug responsive markers (English)

1 reference

10 August 2017

0 references

1 reference

Lisa Martell

1

1 reference

10 August 2017

Kelly Lau

2

1 reference

10 August 2017

Miranda Mei

3

1 reference

10 August 2017

Vicki Burnett

4

1 reference

10 August 2017

Celeste Decker

5

1 reference

10 August 2017

Erik D Foehr

6

1 reference

10 August 2017

publication date

16 December 2011

1 reference

Orphanet Journal of Rare Diseases

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

page(s)

84

1 reference

https://scigraph.springernature.com/pub.10.1186/1750-1172-6-84

10 August 2017

exact match

0 references

cites work

Enzyme replacement in a human model of mucopolysaccharidosis IVA in vitro and its biodistribution in the cartilage of wild type mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Lipoprotein(a): from molecules to therapeutics.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Proteomic analysis of potential keratan sulfate, chondroitin sulfate A, and hyaluronic acid molecular interactions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Current enzyme replacement therapy for the treatment of lysosomal storage diseases.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Enzyme reconstitution/replacement therapy for lysosomal storage diseases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

International Morquio A Registry: clinical manifestation and natural course of Morquio A disease.

12 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1750-1172-6-84

Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1750-1172-6-84

Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1750-1172-6-84

Enzyme replacement therapy in a murine model of Morquio A syndrome.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3280178

Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry

25 September 2018

1 reference

12 December 2020

Early rheumatoid arthritis

1 reference

12 December 2020

Enzyme-replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up

1 reference

12 December 2020

Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome

1 reference

12 December 2020

Enzyme replacement therapy for mucopolysaccharidosis VI from 8 weeks of age--a sibling control study

1 reference

12 December 2020

Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors

1 reference

12 December 2020

Identifiers

DOI

10.1186/1750-1172-6-84

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference